BioMarin Pharmaceuticals
BMRN
BMRN
426 hedge funds and large institutions have $15.6B invested in BioMarin Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 161 increasing their positions, 149 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
426
Holders Change
+8
Holders Change %
+1.91%
% of All Funds
10.64%
Holding in Top 10
14
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+55.56%
% of All Funds
0.35%
New
46
Increased
161
Reduced
149
Closed
36
Calls
$84.4M
Puts
$97.6M
Net Calls
-$13.1M
Net Calls Change
-$19.7M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$304M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$99.8M |
| 3 |
Millennium Management
New York
|
+$80.1M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$79.5M |
| 5 |
UIM
USS Investment Management
London,
United Kingdom
|
+$67.5M |
